|
humans |
40 |
|
female |
29 |
|
microbiology |
29 |
|
male |
28 |
|
biofilm |
26 |
|
adult |
24 |
|
middle aged |
24 |
|
mouth - microbiology |
20 |
|
aged |
18 |
|
candida albicans |
15 |
|
fungi |
15 |
|
cohort studies |
14 |
|
polymerase chain reaction |
14 |
|
adolescent |
13 |
|
candida |
13 |
|
follow-up studies |
13 |
|
genotype |
13 |
|
hong kong |
13 |
|
bacteria |
12 |
|
biofilms |
12 |
|
caries |
12 |
|
colony count, microbial |
12 |
|
oral health |
12 |
|
periodontal index |
12 |
|
antimicrobial agents/inhibitors |
11 |
|
dentistry |
11 |
|
medical sciences |
11 |
|
molecular biology |
11 |
|
oral hygiene |
11 |
|
risk factors |
11 |
|
animals |
10 |
|
anti-bacterial agents - pharmacology |
10 |
|
cell adhesion |
10 |
|
chinese |
10 |
|
dmf index |
10 |
|
infection |
10 |
|
statistics, nonparametric |
10 |
|
age factors |
9 |
|
aged, 80 and over |
9 |
|
antifungal agents - pharmacology |
9 |
|
dna, bacterial - analysis |
9 |
|
immunocompromised host |
9 |
|
longitudinal studies |
9 |
|
saliva |
9 |
|
yeasts |
9 |
|
biofilms - drug effects |
8 |
|
biofilms - growth & development |
8 |
|
china |
8 |
|
china - ethnology |
8 |
|
diabetes mellitus, type 2 - complications |
8 |
|
drug combinations |
8 |
|
health status |
8 |
|
prospective studies |
8 |
|
aids-related opportunistic infections - microbiology |
7 |
|
candida glabrata |
7 |
|
cardiovascular disease |
7 |
|
chlorhexidine |
7 |
|
culture media |
7 |
|
dental caries |
7 |
|
enterobacteriaceae - isolation & purification |
7 |
|
epidemiology |
7 |
|
gene expression |
7 |
|
gram-negative aerobic rods and cocci - classification |
7 |
|
gram-negative facultatively anaerobic rods - classification |
7 |
|
hydrogen-ion concentration |
7 |
|
internet in education. |
7 |
|
periodontal disease |
7 |
|
problem-based learning. |
7 |
|
proteomics |
7 |
|
statistics as topic |
7 |
|
therapeutics |
7 |
|
university of hong kong. faculty of dentistry. |
7 |
|
adhesion |
6 |
|
antifungal agents - therapeutic use |
6 |
|
antimicrobial |
6 |
|
bacterial adhesion |
6 |
|
behavioral science |
6 |
|
biofilms - growth and development |
6 |
|
calcium hydroxide |
6 |
|
candida albicans - isolation & purification |
6 |
|
candidiasis - microbiology |
6 |
|
candidiasis, oral - microbiology |
6 |
|
case-control studies |
6 |
|
chinese medicine |
6 |
|
cross-professional |
6 |
|
dental caries - microbiology |
6 |
|
dental plaque - microbiology |
6 |
|
dental pulp cavity - microbiology |
6 |
|
drug resistance, fungal - genetics |
6 |
|
drugs, chinese herbal - chemistry - pharmacology |
6 |
|
drugs, chinese herbal - pharmacology |
6 |
|
fructus mume |
6 |
|
gene expression regulation, fungal |
6 |
|
genetic variation |
6 |
|
glucose - metabolism |
6 |
|
health services research and learning |
6 |
|
hiv infection |
6 |
|
mouth mucosa - microbiology |
6 |
|
mouthrinses |
6 |
|
orthodontic |
6 |
|
orthodontic brackets - microbiology |
6 |
|
orthodontics |
6 |
|
periapical periodontitis - microbiology |
6 |
|
phenotype |
6 |
|
plant extracts - analysis - pharmacology |
6 |
|
porphyromonas gingivalis - drug effects |
6 |
|
pseudomonas - isolation & purification |
6 |
|
yeast |
6 |
|
actinomyces |
5 |
|
actinomyces - classification - isolation & purification |
5 |
|
amino acid sequence |
5 |
|
anti-infective agents, local - administration and dosage - pharmacology |
5 |
|
antibiotics |
5 |
|
antimicrobial effect |
5 |
|
antimicrobials |
5 |
|
apical periodontitis |
5 |
|
artificial mouth |
5 |
|
aspergillosis |
5 |
|
attitude to health |
5 |
|
bacteria, anaerobic - drug effects - isolation & purification |
5 |
|
bacterial typing techniques |
5 |
|
biofilms - drug effects - growth & development |
5 |
|
blood glucose - analysis |
5 |
|
bone marrow transplantation |
5 |
|
calcium chloride |
5 |
|
calcium hydroxide - pharmacology |
5 |
|
canavalia |
5 |
|
candida - classification |
5 |
|
candida - growth & development - metabolism |
5 |
|
candida - isolation & purification |
5 |
|
candida albicans - enzymology - isolation & purification |
5 |
|
candida albicans - growth & development |
5 |
|
candida albicans - growth & development - physiology - ultrastructure |
5 |
|
candida albicans - pathogenicity |
5 |
|
candida biofilms |
5 |
|
candida species |
5 |
|
candidiasis, oral - epidemiology - microbiology |
5 |
|
chemicals and cas registry numbers |
5 |
|
child |
5 |
|
children |
5 |
|
chlorhexidine - administration and dosage - analogs and derivatives - pharmacology |
5 |
|
confocal scanning laser microscope |
5 |
|
cross-sectional studies |
5 |
|
cyclosporine - therapeutic use |
5 |
|
cytokine |
5 |
|
demeclocycline - pharmacology |
5 |
|
diabetes complications |
5 |
|
diabetes mellitus |
5 |
|
dietary sucrose - metabolism |
5 |
|
differentiation |
5 |
|
diffusion |
5 |
|
disease progression |
5 |
|
drug resistance, fungal |
5 |
|
elderly |
5 |
|
electrophoresis, gel, pulsed-field |
5 |
|
endodontic treatment |
5 |
|
enteric rods |
5 |
|
enterobacteriaceae - classification |
5 |
|
erythrina |
5 |
|
galactose - metabolism |
5 |
|
gingival overgrowth - chemically induced - classification |
5 |
|
gingivitis |
5 |
|
gram-negative bacteria - drug effects |
5 |
|
gram-negative facultatively anaerobic rods - isolation & purification |
5 |
|
gram-positive bacteria - drug effects |
5 |
|
gram-positive rods - isolation & purification |
5 |
|
hatr-ftir |
5 |
|
hemoglobin a, glycosylated - analysis |
5 |
|
hemolysin proteins - biosynthesis |
5 |
|
hiv infections - complications |
5 |
|
hong kong - epidemiology |
5 |
|
hypertension - complications |
5 |
|
immunohistochemistry |
5 |
|
immunology |
5 |
|
immunosuppressive agents - therapeutic use |
5 |
|
indicators and reagents |
5 |
|
kidney transplantation |
5 |
|
lectins |
5 |
|
microscopy, confocal |
5 |
|
microscopy, confocal - methods |
5 |
|
microscopy, electron, scanning |
5 |
|
mouth |
5 |
|
mouth diseases - microbiology |
5 |
|
mouthwashes - administration and dosage - pharmacology |
5 |
|
mucormycosis |
5 |
|
nasopharyngeal carcinoma |
5 |
|
neomycin - pharmacology |
5 |
|
oral |
5 |
|
oral biofilm |
5 |
|
oral microbiology |
5 |
|
organic chemicals |
5 |
|
peptide hydrolases - biosynthesis |
5 |
|
periodontal attachment loss - complications |
5 |
|
periodontal diseases - therapy |
5 |
|
periodontal organisms |
5 |
|
periodontics |
5 |
|
periodontitis - complications |
5 |
|
plant extracts - pharmacology |
5 |
|
plant lectins |
5 |
|
polymers - analysis |
5 |
|
polymyxin b - pharmacology |
5 |
|
potassium chloride |
5 |
|
poverty |
5 |
|
propidium |
5 |
|
prunus |
5 |
|
quorum sensing |
5 |
|
random amplified polymorphic dna technique |
5 |
|
root canal irrigants - pharmacology |
5 |
|
s. mutans and saliva |
5 |
|
sex factors |
5 |
|
sodium bicarbonate |
5 |
|
sodium chloride |
5 |
|
software |
5 |
|
species specificity |
5 |
|
spectroscopy, fourier transform infrared |
5 |
|
stain |
5 |
|
stenotrophomonas maltophilia |
5 |
|
stenotrophomonas maltophilia - isolation & purification |
5 |
|
steroid |
5 |
|
stroke |
5 |
|
sucrose - metabolism |
5 |
|
sugars |
5 |
|
tacrolimus - therapeutic use |
5 |
|
tibetans |
5 |
|
transplantation, homologous |
5 |
|
triamcinolone acetonide - pharmacology |
5 |
|
type 2 diabetes mellitus |
5 |
|
tyrothricin - pharmacology |
5 |
|
2-d dige |
4 |
|
2-de |
4 |
|
acinetobacter - classification |
4 |
|
actinobacillus actinomycetemcomitans - isolation & purification |
4 |
|
actinomyces - isolation & purification - physiology - ultrastructure |
4 |
|
actinomycetes |
4 |
|
actinomycosis - microbiology |
4 |
|
adhesion and aggregation |
4 |
|
adult periodontitis |
4 |
|
animal |
4 |
|
anti-oxidant activity |
4 |
|
antifungal |
4 |
|
antioxidants - physiology |
4 |
|
architecture |
4 |
|
asian continental ancestry group |
4 |
|
atomic force microscopy |
4 |
|
bacteremia - epidemiology - microbiology |
4 |
|
bacteria - classification - growth & development |
4 |
|
bacteria - classification - isolation & purification |
4 |
|
bacteria - drug effects |
4 |
|
bacteria, anaerobic - isolation & purification |
4 |
|
bacterial infections - microbiology |
4 |
|
bacterial physiological phenomena |
4 |
|
bacteriological techniques |
4 |
|
bacteroides - isolation & purification |
4 |
|
biodiversity |
4 |
|
biofilms - drug effects - growth and development |
4 |
|
biomarker |
4 |
|
biomass |
4 |
|
biophysical phenomena |
4 |
|
biophysics |
4 |
|
biopsy |
4 |
|
c. albicans |
4 |
|
candida - drug effects |
4 |
|
candida - growth and development - metabolism - physiology |
4 |
|
candida - pathogenicity |
4 |
|
candida albicans - drug effects |
4 |
|
candida albicans - genetics - pathogenicity - ultrastructure |
4 |
|
candida albicans - physiology |
4 |
|
candida glabrata - drug effects - genetics - metabolism - physiology |
4 |
|
candida glabrata - growth & development |
4 |
|
candida krusei |
4 |
|
candida tropicalis |
4 |
|
candidiasis, oral - physiopathology |
4 |
|
carcinoma - complications - radiotherapy |
4 |
|
carcinoma - radiotherapy |
4 |
|
carcinoma in situ - genetics |
4 |
|
carcinoma, squamous cell - genetics |
4 |
|
caries risk |
4 |
|
cariology and fluoride |
4 |
|
carrier state - microbiology |
4 |
|
cell membrane - microbiology |
4 |
|
cell wall - chemistry |
4 |
|
cftr |
4 |
|
chromosomes, human, pair 21 - genetics |
4 |
|
citrobacter - classification |
4 |
|
clonality |
4 |
|
coliforms |
4 |
|
collagen and demineralization |
4 |
|
collagen i |
4 |
|
confidence intervals |
4 |
|
cystic fibrosis transmembrane conductance regulator - analysis - genetics - metabolism |
4 |
|
demineralization |
4 |
|
dental care |
4 |
|
dental pulp diseases - microbiology |
4 |
|
dental pulp exposure - microbiology |
4 |
|
dental pulp necrosis - microbiology |
4 |
|
dentists |
4 |
|
dentures |
4 |
|
dentures - adverse effects |
4 |
|
dinoprostone - analysis - metabolism |
4 |
|
disease outbreaks |
4 |
|
diversity |
4 |
|
dna, neoplasm - genetics |
4 |
|
drug resistance, bacterial |
4 |
|
drug resistance, multiple, bacterial |
4 |
|
ecology |
4 |
|
electrophoresis, gel, two-dimensional |
4 |
|
endocarditis - epidemiology - microbiology |
4 |
|
enterobacter - classification |
4 |
|
enterobacteriaceae |
4 |
|
enterococcus faecalis |
4 |
|
escherichia - classification |
4 |
|
ethnic groups |
4 |
|
fimbriae |
4 |
|
flavobacterium - classification |
4 |
|
fungi - drug effects - physiology |
4 |
|
gene expression profiling |
4 |
|
genes, tumor suppressor |
4 |
|
genotypes |
4 |
|
gingiva - metabolism - pathology |
4 |
|
gingiva - microbiology |
4 |
|
gingival crevice |
4 |
|
gingival crevicular fluid |
4 |
|
gingival crevicular fluid - immunology - metabolism |
4 |
|
gingival epithelium |
4 |
|
glycolysis |
4 |
|
gram-negative bacteria - chemistry |
4 |
|
granulocyte elastase |
4 |
|
growth kinetics |
4 |
|
health knowledge, attitudes, practice |
4 |
|
hela cells |
4 |
|
image analysis |
4 |
|
immunology and microbiology |
4 |
|
incidence |
4 |
|
inflammation |
4 |
|
inflammatory mediators |
4 |
|
interaction force |
4 |
|
irradiation |
4 |
|
issatchenkia orientalis |
4 |
|
klebsiella - classification |
4 |
|
klebsiella pneumoniae - classification |
4 |
|
lactobacilli |
4 |
|
leukocyte elastase - analysis - metabolism |
4 |
|
lipopolysaccharides - isolation and purification - metabolism |
4 |
|
loss of heterozygosity |
4 |
|
lysozyme |
4 |
|
metagenome |
4 |
|
metagenomics |
4 |
|
microbial sensitivity tests |
4 |
|
microbial viability |
4 |
|
microbiology and nucleic acids |
4 |
|
microsatellite repeats |
4 |
|
microscopy, atomic force |
4 |
|
microscopy, fluorescence |
4 |
|
mouth - microbiology - radiation effects |
4 |
|
mouth mucosa - cytology - microbiology |
4 |
|
mouth neoplasms - genetics |
4 |
|
mouthwashes - therapeutic use |
4 |
|
nasopharyngeal neoplasms - complications - radiotherapy |
4 |
|
nasopharyngeal neoplasms - radiotherapy |
4 |
|
neisseria - classification |
4 |
|
neoplasm invasiveness - genetics |
4 |
|
neoplasm recurrence, local - genetics |
4 |
|
neoplasm staging |
4 |
|
nucleic acid hybridization |
4 |
|
odds ratio |
4 |
|
oligonucleotide probes |
4 |
|
oligonucleotide-dna hybridization |
4 |
|
oral candidiasis |
4 |
|
oropharynx |
4 |
|
periodontal diseases - microbiology |
4 |
|
periodontitis - enzymology - immunology - microbiology |
4 |
|
periodontopathogen |
4 |
|
pge2 |
4 |
|
phospholipase |
4 |
|
polymorphism, genetic |
4 |
|
polymorphism, restriction fragment length |
4 |
|
polystyrenes |
4 |
|
porphyromonas gingivalis - isolation & purification |
4 |
|
prevotella intermedia - isolation & purification |
4 |
|
proteins |
4 |
|
proteoglycans |
4 |
|
proteomics - methods |
4 |
|
pseudomonas - classification |
4 |
|
rats |
4 |
|
rats, sprague-dawley |
4 |
|
reconstituted human oral epithelium |
4 |
|
rehabilitation |
4 |
|
resistance |
4 |
|
rna, ribosomal, 16s - analysis |
4 |
|
root |
4 |
|
root canal infection |
4 |
|
root-canal bacteria |
4 |
|
sequencing |
4 |
|
species index: candida |
4 |
|
streptococci |
4 |
|
stress response |
4 |
|
stress, physiological |
4 |
|
subgingival plaque |
4 |
|
tooth - microbiology |
4 |
|
tooth diseases - microbiology |
4 |
|
tooth injuries - microbiology |
4 |
|
toothbrushing |
4 |
|
treponema - isolation & purification |
4 |
|
viability |
4 |
|
virulence |
4 |
|
xerostomia |
4 |
|
xerostomia - complications |
4 |
|
xerostomia - etiology - microbiology |
4 |
|
3d cell sheet |
3 |
|
acrylic resins |
3 |
|
actinomyces viscosus - isolation & purification |
3 |
|
adaptation, physiological |
3 |
|
adenosine triphosphate - analysis |
3 |
|
adherence |
3 |
|
adherence and colonization |
3 |
|
aids-related opportunistic infections - drug therapy - microbiology |
3 |
|
amphotericin b |
3 |
|
amphotericin b - therapeutic use |
3 |
|
analysis of variance |
3 |
|
anti-candidal activity |
3 |
|
anti-candidal salivary factors |
3 |
|
antifungal agents - analysis - pharmacology |
3 |
|
antifungal agents - metabolism - pharmacology |
3 |
|
antifungal drug |
3 |
|
antifungal resistance |
3 |
|
antifungal susceptibility |
3 |
|
antifungal susceptibility testing |
3 |
|
antifungals |
3 |
|
antimicrobial activity |
3 |
|
aspartic acid endopeptidases - analysis |
3 |
|
aspirin - therapeutic use |
3 |
|
atp bioluminescence |
3 |
|
autoinducer |
3 |
|
b-lymphocytes - virology |
3 |
|
bacteria - growth & development |
3 |
|
bacterial colonization |
3 |
|
base sequence |
3 |
|
biology |
3 |
|
bioreactors - standards |
3 |
|
biotypes |
3 |
|
blood-borne pathogens |
3 |
|
bloodstream isolates |
3 |
|
blotting, southern |
3 |
|
blotting, western |
3 |
|
c. albicans biofilms |
3 |
|
candida - classification - drug effects - genetics - isolation & purification |
3 |
|
candida - classification - drug effects - physiology |
3 |
|
candida - drug effects - growth & development |
3 |
|
candida - drug effects - growth & development - isolation & purification |
3 |
|
candida - drug effects - physiology - ultrastructure |
3 |
|
candida - growth & development - physiology |
3 |
|
candida albicans - chemistry - drug effects |
3 |
|
candida albicans - classification - drug effects |
3 |
|
candida albicans - classification - drug effects - genetics - isolation & purification |
3 |
|
candida albicans - classification - drug effects - growth & development |
3 |
|
candida albicans - classification - genetics |
3 |
|
candida albicans - drug effects - growth & development - ultrastructure |
3 |
|
candida albicans - genetics - pathogenicity |
3 |
|
candida carriers and non-carriers |
3 |
|
candida dubliniensis |
3 |
|
candida glabrata - isolation & purification |
3 |
|
candida tropicalis - isolation & purification |
3 |
|
candidiasis |
3 |
|
candidiasis, oral - complications - drug therapy - microbiology - pathology |
3 |
|
candidiasis, oral - complications - epidemiology - microbiology |
3 |
|
candidiasis, oral - complications - microbiology |
3 |
|
candidiasis, oral - drug therapy - microbiology |
3 |
|
candidiasis, oral - immunology |
3 |
|
candidiasis, oral - immunology - microbiology - pathology |
3 |
|
candidiasis, oral - microbiology - pathology |
3 |
|
candidosis |
3 |
|
carbohydrate metabolism |
3 |
|
carcinogen |
3 |
|
carcinoma - microbiology - radiotherapy |
3 |
|
cardiovascular disease and quality of life |
3 |
|
carrier state - epidemiology - microbiology |
3 |
|
carrier state - immunology - microbiology - pathology |
3 |
|
cell biology |
3 |
|
cell culture |
3 |
|
cell line |
3 |
|
cell-cell signaling |
3 |
|
cerebral palsy |
3 |
|
chi-square distribution |
3 |
|
child, preschool |
3 |
|
chinese preschool children |
3 |
|
chronic periodontitis |
3 |
|
clinical effectiveness |
3 |
|
clinical isolates |
3 |
|
cluster analysis |
3 |
|
colony count, microbial - methods |
3 |
|
coronavirus pneumonia infection |
3 |
|
cranial irradiation |
3 |
|
crevicular fluid |
3 |
|
cross infection - prevention & control |
3 |
|
cross infection - prevention & control - psychology - transmission |
3 |
|
cryptococcosis |
3 |
|
cyclophosphamide |
3 |
|
debridement |
3 |
|
dental caries - epidemiology - microbiology |
3 |
|
dental enamel - microbiology |
3 |
|
dental health |
3 |
|
dental office |
3 |
|
dental plaque - epidemiology - microbiology |
3 |
|
dental service, hospital |
3 |
|
denture acrylic |
3 |
|
denture bases - microbiology |
3 |
|
denture cleanliness |
3 |
|
denture hygiene |
3 |
|
denture plaque |
3 |
|
denture, complete, upper - adverse effects |
3 |
|
diagnostics |
3 |
|
diet, vegetarian |
3 |
|
dietary carbohydrates - administration & dosage |
3 |
|
dietary carbohydrates - pharmacology |
3 |
|
disease models, animal |
3 |
|
disinfectants - pharmacology |
3 |
|
dna primers |
3 |
|
dose-response relationship, drug |
3 |
|
drug evaluation, preclinical - methods |
3 |
|
drug resistance, microbial - genetics |
3 |
|
drug synergism |
3 |
|
epithelial cells |
3 |
|
epithelial cells - metabolism - microbiology |
3 |
|
epithelial cells - microbiology |
3 |
|
epithelium - microbiology |
3 |
|
epithelium - microbiology - pathology |
3 |
|
epstein-barr virus |
3 |
|
equipment contamination |
3 |
|
escherichia coli - physiology |
3 |
|
eye protective devices |
3 |
|
fluconazole |
3 |
|
fluconazole - pharmacology |
3 |
|
fluconazole - therapeutic use |
3 |
|
food handling |
3 |
|
fungal proteins - analysis |
3 |
|
fungal proteins - metabolism |
3 |
|
fungi - physiology |
3 |
|
galactose - administration & dosage - metabolism |
3 |
|
gene expression regulation, bacterial |
3 |
|
glucose - administration & dosage - metabolism |
3 |
|
gram-negative bacteria - isolation & purification |
3 |
|
gram-negative rods |
3 |
|
growth & development |
3 |
|
head and neck irradiation |
3 |
|
health promotion |
3 |
|
herpesvirus 4, human - physiology |
3 |
|
histoplasmosis |
3 |
|
hiv infections - complications - microbiology |
3 |
|
hiv infections - microbiology |
3 |
|
hiv-infection |
3 |
|
hospitalization |
3 |
|
hospitals, teaching |
3 |
|
human umbilical vein endothelial cells |
3 |
|
hypha |
3 |
|
hyphae |
3 |
|
image processing, computer-assisted |
3 |
|
immune response |
3 |
|
immunoglobulin a, secretory - analysis |
3 |
|
immunosuppression |
3 |
|
immunosuppressive agents |
3 |
|
indices |
3 |
|
indoles - pharmacology |
3 |
|
infection control, dental - instrumentation - methods |
3 |
|
infectious disease transmission, patient-to-professional - prevention & control |
3 |
|
institutionalization |
3 |
|
interactome |
3 |
|
interviews as topic |
3 |
|
ketoconazole - therapeutic use |
3 |
|
kinetics |
3 |
|
klebsiella pneumoniae - isolation & purification |
3 |
|
lactoferrin - analysis |
3 |
|
lactoferrin - pharmacology |
3 |
|
leprosy - complications |
3 |
|
leukocyte count |
3 |
|
life style |
3 |
|
lipopolysaccharide |
3 |
|
lipopolysaccharides - metabolism - pharmacology |
3 |
|
logistic models |
3 |
|
masks |
3 |
|
metabolism |
3 |
|
metastatsis |
3 |
|
metergoline |
3 |
|
methylmethacrylates - metabolism |
3 |
|
microbial sensitivity tests - methods |
3 |
|
microbiology and oral biology |
3 |
|
microbiology and plaque |
3 |
|
mouth cavity |
3 |
|
mouth flora |
3 |
|
mouth mucosa - microbiology - pathology |
3 |
|
mouth mucosa - virology |
3 |
|
muramidase - analysis |
3 |
|
muramidase - pharmacology |
3 |
|
mutation |
3 |
|
mycological typing techniques |
3 |
|
mycoses - drug therapy - microbiology - pathology |
3 |
|
nasopharyngeal neoplasms - microbiology - radiotherapy |
3 |
|
neisseriaceae - isolation & purification |
3 |
|
neoplasms - blood supply - chemistry - metabolism - therapy |
3 |
|
new infection |
3 |
|
nystatin - pharmacology |
3 |
|
opportunistic infections - microbiology |
3 |
|
oral biology |
3 |
|
oral health promotion |
3 |
|
oral manifestations |
3 |
|
oral microbial carriage |
3 |
|
oral prevalence |
3 |
|
organosilicon compounds - pharmacology |
3 |
|
oropharynx - microbiology |
3 |
|
orthodontic appliances - adverse effects |
3 |
|
orthodontic appliances - microbiology |
3 |
|
orthodontics - instrumentation |
3 |
|
patient discharge |
3 |
|
periodontal ligament stem cells |
3 |
|
periodontal pocket - microbiology |
3 |
|
periodontium-gingiva |
3 |
|
pharyngeal diseases - microbiology |
3 |
|
phenotypic switching |
3 |
|
photodynamic therapy |
3 |
|
photosensitiser |
3 |
|
photosensitizing agents - pharmacology |
3 |
|
phthalocyanine |
3 |
|
physical disability |
3 |
|
planimetry |
3 |
|
plankton - growth & development |
3 |
|
plaque biofilm |
3 |
|
plasma protein binding |
3 |
|
platelet aggregation inhibitors - therapeutic use |
3 |
|
prevalence |
3 |
|
private practice |
3 |
|
protective devices |
3 |
|
proteome |
3 |
|
proteome - analysis |
3 |
|
pseudomonas |
3 |
|
random allocation |
3 |
|
recurrence |
3 |
|
regeneration |
3 |
|
regeneration and tissue engineering |
3 |
|
regression analysis |
3 |
|
review |
3 |
|
root canal therapy |
3 |
|
root caries |
3 |
|
rotating disc |
3 |
|
saccharomyces cerevisiae - isolation & purification |
3 |
|
saliva - chemistry - microbiology - physiology |
3 |
|
saliva - metabolism |
3 |
|
saliva - microbiology |
3 |
|
secretory rate - physiology |
3 |
|
sequence analysis, dna |
3 |
|
sequential isolates |
3 |
|
serotyping |
3 |
|
severe acute respiratory syndrome - prevention & control - psychology - transmission |
3 |
|
shedding |
3 |
|
signal transduction |
3 |
|
singapore |
3 |
|
south-east asia |
3 |
|
southern hybridization |
3 |
|
spores, fungal - drug effects - growth & development |
3 |
|
staphylococcal infections - complications |
3 |
|
stem cells and tissue engineering |
3 |
|
streptococcus mitis |
3 |
|
streptococcus mutans |
3 |
|
streptococcus sanguis |
3 |
|
stroke - microbiology |
3 |
|
supragingival plaque |
3 |
|
synergism |
3 |
|
time factors |
3 |
|
tissue engineering |
3 |
|
tongue - microbiology - pathology |
3 |
|
tooth, deciduous - microbiology |
3 |
|
toothbrushes |
3 |
|
transforming growth factor beta1 - metabolism |
3 |
|
transforming growth factor-β1 |
3 |
|
vegetarians |
3 |
|
virulence attributes |
3 |
|
virulence factors |
3 |
|
virus shedding - physiology |
3 |
|
virus-loaded aerosol |
3 |
|
xtt reduction assay |
3 |
|
yeasts - isolation & purification |
3 |
|
young adult |
3 |
|
5' flanking region |
2 |
|
absorption layer |
2 |
|
acids - metabolism |
2 |
|
acquired immunodeficiency syndrome - prevention & control - transmission |
2 |
|
acrylic |
2 |
|
actinomyces - classification - genetics |
2 |
|
actinomyces - classification - genetics - pathogenicity |
2 |
|
actinomyces - growth & development - metabolism - pathogenicity |
2 |
|
actinomyces viscosus - classification - genetics |
2 |
|
actinomycosis - drug therapy - microbiology |
2 |
|
acylation |
2 |
|
adenine - metabolism |
2 |
|
adhesive bonding |
2 |
|
aerobiosis |
2 |
|
africa |
2 |
|
aids |
2 |
|
aids-related opportunistic infections - complications |
2 |
|
amine fluoride |
2 |
|
amphotericin b - antagonists & inhibitors - pharmacology |
2 |
|
amphotericin b - metabolism - pharmacology |
2 |
|
anaerobic |
2 |
|
anaerobiosis |
2 |
|
anemia, hypochromic - etiology |
2 |
|
angular cheilitis |
2 |
|
antagonism |
2 |
|
anti-bacterial agents - therapeutic use |
2 |
|
anti-infective agents - analysis |
2 |
|
anti-infective agents - pharmacology |
2 |
|
antibodies, monoclonal - immunology |
2 |
|
antibodies, protozoan - genetics - immunology |
2 |
|
antifungal agents - antagonists & inhibitors - pharmacology |
2 |
|
antifungal agents - pharmacology - therapeutic use |
2 |
|
antigens, cd1 - analysis |
2 |
|
antigens, cd14 - biosynthesis - genetics |
2 |
|
antigens, protozoan - genetics - immunology |
2 |
|
antigens, surface - immunology |
2 |
|
antiretroviral therapy, highly active - adverse effects |
2 |
|
apoproteins - pharmacology |
2 |
|
appressoria |
2 |
|
areca |
2 |
|
aspartic acid endopeptidases - genetics |
2 |
|
aspartic acid endopeptidases - metabolism |
2 |
|
aspartic endopeptidases - antagonists & inhibitors - metabolism - secretion |
2 |
|
australia - epidemiology |
2 |
|
bacteria - classification - growth & development - isolation & purification |
2 |
|
bacteria - isolation & purification - ultrastructure |
2 |
|
bacteria, aerobic - physiology |
2 |
|
bacteria, anaerobic - physiology |
2 |
|
bacterial adhesion - physiology |
2 |
|
bacterial coaggregation |
2 |
|
bacterial dierentiation |
2 |
|
bacteroidaceae infections - complications - immunology |
2 |
|
beta-defensins - analysis |
2 |
|
beta-defensins - biosynthesis - genetics |
2 |
|
beta-defensins - genetics - metabolism |
2 |
|
biocides |
2 |
|
biological assay |
2 |
|
bisexuality |
2 |
|
buccal epithelial cells |
2 |
|
c. glabrata |
2 |
|
calcium hydroxide - therapeutic use |
2 |
|
candida - classification - drug effects |
2 |
|
candida - classification - drug effects - growth & development - ultrastructure |
2 |
|
candida - classification - genetics - immunology |
2 |
|
candida - classification - isolation & purification |
2 |
|
candida - drug effects - growth & development - pathogenicity |
2 |
|
candida - drug effects - isolation & purification - ultrastructure |
2 |
|
candida - enzymology - growth & development - pathogenicity |
2 |
|
candida - enzymology - pathogenicity - physiology |
2 |
|
candida - genetics - isolation & purification - pathogenicity |
2 |
|
candida - genetics - metabolism - radiation effects |
2 |
|
candida - genetics - pathogenicity |
2 |
|
candida - physiology |
2 |
|
candida - physiology - ultrastructure |
2 |
|
candida albicans - chemistry - genetics - isolation & purification - physiology |
2 |
|
candida albicans - classification |
2 |
|
candida albicans - classification - genetics - isolation & purification |
2 |
|
candida albicans - cytology - drug effects - physiology |
2 |
|
candida albicans - cytology - enzymology - ultrastructure |
2 |
|
candida albicans - drug effects - genetics - growth & development |
2 |
|
candida albicans - drug effects - genetics - growth and development |
2 |
|
candida albicans - drug effects - genetics - isolation & purification |
2 |
|
candida albicans - drug effects - growth & development |
2 |
|
candida albicans - drug effects - physiology |
2 |
|
candida albicans - enzymology - genetics - growth & development - isolation & purification |
2 |
|
candida albicans - enzymology - growth & development - pathogenicity |
2 |
|
candida albicans - genetics - growth & development - isolation & purification - pathogenicity |
2 |
|
candida albicans - genetics - physiology - ultrastructure |
2 |
|
candida albicans - growth and development - ultrastructure |
2 |
|
candida albicans - immunology |
2 |
|
candida albicans - metabolism - pathogenicity |
2 |
|
candida albicans - physiology - ultrastructure |
2 |
|
candida glabrata - physiology - ultrastructure |
2 |
|
candida tropicalis - immunology |
2 |
|
candida tropicalis - physiology - ultrastructure |
2 |
|
candida-tropicalis-genetics |
2 |
|
candidiasis - complications |
2 |
|
candidiasis - drug therapy |
2 |
|
candidiasis - drug therapy - epidemiology - microbiology |
2 |
|
candidiasis, oral - complications |
2 |
|
candidiasis, oral - epidemiology - microbiology - physiopathology |
2 |
|
candidiasis, oral - ethnology - etiology |
2 |
|
candidiasis, oral - etiology - microbiology |
2 |
|
candidiasis, oral - immunology - pathology |
2 |
|
candidiasis, oral - microbiology - physiopathology |
2 |
|
candidiasis,-oral-epidemiology |
2 |
|
candidiasis,-oral-microbiology |
2 |
|
candy |
2 |
|
carbohydrate |
2 |
|
carbohydrates |
2 |
|
carbohydrates - pharmacology |
2 |
|
caries-affected dentine |
2 |
|
caries-associated microflora |
2 |
|
cariogenicity and artificial caries |
2 |
|
catheters |
2 |
|
cattle |
2 |
|
cd4 lymphocyte count |
2 |
|
cell adhesion - physiology |
2 |
|
cell count |
2 |
|
cell culture techniques |
2 |
|
cell line, tumor |
2 |
|
cell membrane - physiology |
2 |
|
cell-surface-hydrophobicity |
2 |
|
cells, cultured |
2 |
|
centers for disease control and prevention (u.s.) |
2 |
|
cheilitis - complications - microbiology - pathology |
2 |
|
chemomechanical caries removal |
2 |
|
chemoprophylaxis |
2 |
|
chlorhexidine - analogs & derivatives - pharmacology |
2 |
|
chronic disease |
2 |
|
chronic periodontitis - etiology - immunology |
2 |
|
coculture techniques |
2 |
|
colonization |
2 |
|
computer simulation |
2 |
|
covid-19 |
2 |
|
cricetinae |
2 |
|
culicidae - parasitology |
2 |
|
cultural deprivation |
2 |
|
culture |
2 |
|
curriculum |
2 |
|
cytoplasm - ultrastructure |
2 |
|
databases, factual |
2 |
|
demography |
2 |
|
dental caries - etiology - microbiology |
2 |
|
dental caries - metabolism - microbiology |
2 |
|
dental caries - therapy |
2 |
|
dental caries activity tests |
2 |
|
dental cavity preparation - instrumentation |
2 |
|
dental equipment |
2 |
|
dental high-speed equipment |
2 |
|
dental instruments |
2 |
|
dental plaque |
2 |
|
dental plaque - metabolism - microbiology |
2 |
|
dental pulp cavity - drug effects - microbiology |
2 |
|
dental research |
2 |
|
dental research - methods |
2 |
|
dental staff |
2 |
|
dentinal tubule |
2 |
|
disease |
2 |
|
disinfection - methods |
2 |
|
dna fingerprinting |
2 |
|
dna primers - genetics |
2 |
|
dna, bacterial - analysis - genetics |
2 |
|
dna, fungal - genetics |
2 |
|
dna, fungal - genetics - isolation & purification |
2 |
|
dna, ribosomal - genetics |
2 |
|
dna-fingerprinting |
2 |
|
drug evaluation, preclinical |
2 |
|
drug interaction |
2 |
|
drug interactions |
2 |
|
drug resistance, microbial |
2 |
|
drug therapy, combination |
2 |
|
dual species biofilm |
2 |
|
dynamic |
2 |
|
ebolavirus - physiology |
2 |
|
education, dental - organization & administration |
2 |
|
endocarditis, bacterial |
2 |
|
endocarditis, bacterial - prevention & control |
2 |
|
endodontic bacteria |
2 |
|
endodontic infection |
2 |
|
endodontic microbiology |
2 |
|
endodontic therapy |
2 |
|
endophthalmitis - drug therapy - epidemiology - microbiology |
2 |
|
england - epidemiology |
2 |
|
enterobacter cloacae - isolation & purification |
2 |
|
enterobacteriaceae - cytology - isolation & purification |
2 |
|
enterobacteriaceae - pathogenicity |
2 |
|
epithelium - drug effects - immunology - metabolism - pathology |
2 |
|
epithelium - immunology - microbiology |
2 |
|
epithelium - microbiology - physiology |
2 |
|
epithelium - pathology |
2 |
|
epitopes |
2 |
|
equipment contamination - prevention & control |
2 |
|
escherichia |
2 |
|
escherichia coli |
2 |
|
escherichia coli - cytology - drug effects - physiology |
2 |
|
evolution |
2 |
|
extracellular matrix - physiology |
2 |
|
extracellular space |
2 |
|
extracellular space - drug effects - enzymology |
2 |
|
eye infections, fungal - drug therapy - epidemiology - microbiology |
2 |
|
family |
2 |
|
fimbriae, bacterial - physiology |
2 |
|
fingerprinting |
2 |
|
fixed orthodontic appliance |
2 |
|
flow rate |
2 |
|
fluconazole resistance |
2 |
|
fluconazole-resistance |
2 |
|
food habits |
2 |
|
framycetin - therapeutic use |
2 |
|
framycetin sulfate |
2 |
|
fungal proteins - genetics |
2 |
|
fungal proteins - genetics - metabolism |
2 |
|
galactose - pharmacology |
2 |
|
gene expression - physiology |
2 |
|
gene expression regulation - drug effects - immunology |
2 |
|
gene expression regulation, enzymologic |
2 |
|
gene expression regulation, fungal - drug effects |
2 |
|
genes, fungal |
2 |
|
genes, recessive |
2 |
|
genetic diversity |
2 |
|
genome, fungal |
2 |
|
germany - epidemiology |
2 |
|
gingiva - microbiology - pathology |
2 |
|
gingiva - pathology |
2 |
|
gingival epithelia |
2 |
|
glucose - pharmacology |
2 |
|
gram-positive bacteria - physiology |
2 |
|
granulation tissue - pathology |
2 |
|
great britain |
2 |
|
haart |
2 |
|
health behavior |
2 |
|
health education |
2 |
|
hemolysin |
2 |
|
hemolysin proteins - metabolism |
2 |
|
hemorrhagic fever, ebola - diagnosis - prevention & control - therapy - transmission |
2 |
|
heterozygote |
2 |
|
histochemistry |
2 |
|
histocytochemistry |
2 |
|
hiv |
2 |
|
hiv infections - complications - drug therapy - ethnology - pathology |
2 |
|
hiv infections - complications - physiopathology |
2 |
|
hiv infections - enzymology |
2 |
|
hiv infections - microbiology - pathology |
2 |
|
hiv infections - prevention & control - transmission |
2 |
|
hiv infections - transmission |
2 |
|
hiv-1 |
2 |
|
homosexuality |
2 |
|
homosexuality, male |
2 |
|
hong kong chinese |
2 |
|
host-microbial interactions |
2 |
|
host-pathogen interactions |
2 |
|
human β-defensin-3 |
2 |
|
human β-defensins |
2 |
|
hybridization |
2 |
|
hydrophobic and hydrophilic interactions |
2 |
|
hydrophobicity |
2 |
|
hyphae - genetics |
2 |
|
hyphae - genetics - growth & development |
2 |
|
hyphae - physiology |
2 |
|
hyphae - physiology - ultrastructure |
2 |
|
hyphal mutants |
2 |
|
immune reconstitution inflammatory syndrome |
2 |
|
immune reconstitution inflammatory syndrome - complications - diagnosis - etiology - therapy |
2 |
|
immunity, innate |
2 |
|
in situ hybridization |
2 |
|
incubation conditions |
2 |
|
infection and serum-plasma |
2 |
|
infection control |
2 |
|
infection control - methods |
2 |
|
infection control, dental - methods |
2 |
|
infectious disease transmission, patient-to-professional |
2 |
|
infectious disease transmission, professional-to-patient |
2 |
|
information services |
2 |
|
intercellular junctions - microbiology |
2 |
|
interface |
2 |
|
interleukin-1alpha - analysis |
2 |
|
interleukin-8 - analysis |
2 |
|
intermediate filament proteins - analysis |
2 |
|
internalization |
2 |
|
international |
2 |
|
international cooperation |
2 |
|
introns |
2 |
|
isoenzymes - biosynthesis - genetics |
2 |
|
iysozyme |
2 |
|
karyotyping |
2 |
|
keratin-20 |
2 |
|
keratinocytes |
2 |
|
keratinocytes - cytology - microbiology - physiology |
2 |
|
keratinocytes - pathology |
2 |
|
keratins - genetics |
2 |
|
lactobacillus - growth & development - metabolism - pathogenicity |
2 |
|
lactobacillus - isolation & purification |
2 |
|
lactoferrin |
2 |
|
lactose - pharmacology |
2 |
|
langerhans cells - pathology |
2 |
|
leprosy - microbiology |
2 |
|
leukoplakia, hairy - ethnology - etiology |
2 |
|
leukoplakia, oral - etiology |
2 |
|
linear models |
2 |
|
lipid a - analogs & derivatives - pharmacology |
2 |
|
lysophospholipase - analysis |
2 |
|
lysophospholipase - metabolism |
2 |
|
malaria - immunology |
2 |
|
maltose - pharmacology |
2 |
|
management information systems |
2 |
|
media |
2 |
|
merkel cells - pathology |
2 |
|
metallothionein |
2 |
|
microbial invasion |
2 |
|
microbiological techniques |
2 |
|
microflora |
2 |
|
microscopy, electron, scanning - methods |
2 |
|
microscopy, electron, transmission |
2 |
|
models |
2 |
|
models, biological |
2 |
|
molar - microbiology - pathology |
2 |
|
molecular diagnostic techniques - methods |
2 |
|
molecular sequence data |
2 |
|
molecular weight |
2 |
|
mouth - metabolism - microbiology |
2 |
|
mouth diseases - complications |
2 |
|
mouth diseases - ethnology - etiology |
2 |
|
mouth diseases - virology |
2 |
|
mouth mucosa - cytology - immunology - microbiology |
2 |
|
mucosal explants |
2 |
|
multi-centre |
2 |
|
multivariate analysis |
2 |
|
muramidase - metabolism |
2 |
|
muramidase - metabolism - pharmacology |
2 |
|
mutagenesis |
2 |
|
mutation - genetics |
2 |
|
mycology - methods |
2 |
|
mycoses |
2 |
|
non-albicans candida |
2 |
|
nursing homes |
2 |
|
occupational exposure |
2 |
|
oligonucleotide probes - diagnostic use |
2 |
|
oral bacteria |
2 |
|
oral cavity |
2 |
|
oral ulcer - ethnology - etiology |
2 |
|
orofacial |
2 |
|
ovum - immunology |
2 |
|
oxygen - pharmacology |
2 |
|
pafe |
2 |
|
parent-child relations |
2 |
|
parenting |
2 |
|
parotid gland - secretion |
2 |
|
patients |
2 |
|
pcr |
2 |
|
peptide hydrolases - metabolism |
2 |
|
periodontal pocket - pathology |
2 |
|
periodontitis - pathology |
2 |
|
periodontium - pathology |
2 |
|
pfge, rapd |
2 |
|
ph |
2 |
|
phenotypes |
2 |
|
phospholipase gene expression |
2 |
|
phospholipases - biosynthesis - genetics |
2 |
|
phospholipases a - analysis |
2 |
|
phylogeny |
2 |
|
plankton - drug effects - growth & development |
2 |
|
plaque |
2 |
|
plasmodium vivax - immunology - pathogenicity |
2 |
|
poly(methyl methacrylate) |
2 |
|
polymethyl methacrylate - chemistry |
2 |
|
polysaccharides |
2 |
|
porphyromonas gingivalis |
2 |
|
porphyromonas gingivalis - immunology - pathogenicity |
2 |
|
practice guidelines |
2 |
|
practice guidelines as topic |
2 |
|
primary dentition |
2 |
|
problem-based learning - organization & administration |
2 |
|
proteolysis |
2 |
|
rabbits |
2 |
|
random amplified polymorphic dna technique - methods |
2 |
|
receptors, interleukin-1 type i - analysis |
2 |
|
retrospective studies |
2 |
|
reverse transcriptase polymerase chain reaction |
2 |
|
rflp |
2 |
|
rheology |
2 |
|
rhoe |
2 |
|
rna, fungal - chemistry - genetics |
2 |
|
rna, messenger - metabolism |
2 |
|
rna, ribosomal, 16s - genetics |
2 |
|
root caries - microbiology |
2 |
|
root caries - microbiology - pathology |
2 |
|
saccharolysis |
2 |
|
saliva - chemistry - enzymology - secretion |
2 |
|
saliva - chemistry - microbiology |
2 |
|
saliva - enzymology |
2 |
|
salivary glands - secretion |
2 |
|
salivary proteins and peptides - analysis - metabolism |
2 |
|
sars virus - physiology |
2 |
|
secretory rate |
2 |
|
sensitivity and specificity |
2 |
|
severe acute respiratory syndrome - prevention & control - transmission |
2 |
|
sexuality |
2 |
|
socio-economic status |
2 |
|
socioeconomic factors |
2 |
|
spectrophotometry - methods |
2 |
|
sri lanka |
2 |
|
sri lankans |
2 |
|
stannous fluoride |
2 |
|
staphylococcus aureus - isolation & purification |
2 |
|
sterilization |
2 |
|
stomatitis, herpetic - ethnology - etiology |
2 |
|
streptococcus - isolation & purification - ultrastructure |
2 |
|
streptococcus mutans - growth & development - metabolism - pathogenicity |
2 |
|
streptococcus mutans - isolation & purification |
2 |
|
students |
2 |
|
students, dental |
2 |
|
sucrose - pharmacology |
2 |
|
surface properties |
2 |
|
susceptibility |
2 |
|
systematic review |
2 |
|
systemic |
2 |
|
teaching |
2 |
|
television |
2 |
|
tetrazolium salts - diagnostic use |
2 |
|
thigmotropism |
2 |
|
thymidine - diagnostic use |
2 |
|
tissue culture techniques |
2 |
|
toll-like receptor |
2 |
|
toll-like receptor 2 - biosynthesis - genetics |
2 |
|
toll-like receptor 4 - biosynthesis - genetics |
2 |
|
tongue |
2 |
|
tooth demineralization - microbiology |
2 |
|
tooth root - microbiology - pathology |
2 |
|
travel |
2 |
|
treatment outcome |
2 |
|
ultrastructure |
2 |
|
ultraviolet rays |
2 |
|
united states |
2 |
|
universal precautions |
2 |
|
up-regulation |
2 |
|
user-computer interface |
2 |
|
virulence factors - metabolism |
2 |
|
water microbiology |
2 |
|
world health organization |
2 |
|
xerostomia - ethnology - etiology |
2 |
|
xtt |
2 |
|
xylitol - pharmacology |
2 |
|
zidovudine - therapeutic use |
2 |
|
5- fluorocytosine |
1 |
|
5-fluorocytosine |
1 |
|
abo blood-group system |
1 |
|
abo blood-group system - genetics |
1 |
|
abscess - drug therapy |
1 |
|
academies and institutes |
1 |
|
acetates - analysis |
1 |
|
acetates - metabolism |
1 |
|
acid phosphatase |
1 |
|
acid phosphatase - metabolism |
1 |
|
acquired immunodeficiency syndrome |
1 |
|
acquired immunodeficiency syndrome - complications |
1 |
|
acquired immunodeficiency syndrome - diagnosis |
1 |
|
acquired immunodeficiency syndrome - epidemiology - microbiology - pathology - prevention & control - transmission |
1 |
|
acquired immunodeficiency syndrome - epidemiology - transmission |
1 |
|
acquired immunodeficiency syndrome - psychology - transmission |
1 |
|
acquired immunodeficiency syndrome - transmission |
1 |
|
acryl |
1 |
|
acrylates |
1 |
|
acrylic resins - chemistry |
1 |
|
acrylic resins - metabolism |
1 |
|
actinobacillus - metabolism |
1 |
|
actinobacillus actinomycetemcomitans - drug effects |
1 |
|
actinobacillus infections - drug therapy |
1 |
|
actinomyces - isolation & purification |
1 |
|
actinomyces - isolation & purification - physiology |
1 |
|
actinomyces - metabolism |
1 |
|
acute disease |
1 |
|
adhesiveness |
1 |
|
administration, inhalation |
1 |
|
administration, oral |
1 |
|
administration, topical |
1 |
|
aerosols |
1 |
|
age distribution |
1 |
|
aids- related opportunistic |
1 |
|
aids-related opportunistic infections - classification |
1 |
|
aids-related opportunistic infections - classification - drug therapy |
1 |
|
aids-related opportunistic infections - classification - epidemiology |
1 |
|
aids-related opportunistic infections - complications - drug therapy - microbiology |
1 |
|
aids-related opportunistic infections - complications - microbiology |
1 |
|
aids-related opportunistic infections - diagnosis |
1 |
|
aids-related opportunistic infections - drug therapy |
1 |
|
aids-related opportunistic infections - epidemiology |
1 |
|
aids-related opportunistic infections - epidemiology - microbiology |
1 |
|
aids-related opportunistic infections - immunology - microbiology |
1 |
|
aids-related opportunistic infections - immunology - pathology |
1 |
|
aids-related opportunistic infections - pathology |
1 |
|
aids-related opportunistic infections - therapy |
1 |
|
air microbiology |
1 |
|
air pollutants, occupational |
1 |
|
air pollutants, occupational - adverse effects |
1 |
|
air pollutants, occupational - isolation & purification |
1 |
|
air pollution - prevention & control |
1 |
|
alberta - epidemiology |
1 |
|
alginates |
1 |
|
alkaline phosphatase |
1 |
|
alkaline phosphatase - metabolism |
1 |
|
amines - adverse effects - therapeutic use |
1 |
|
amines - pharmacology |
1 |
|
amines - therapeutic use |
1 |
|
amphotericin b - administration & dosage - pharmacology |
1 |
|
amphotericin b - administration & dosage - therapeutic use |
1 |
|
amphotericin b - pharmacology |
1 |
|
amphotericin b - pharmacology - therapeutic use |
1 |
|
ampicillin - pharmacology |
1 |
|
anaerobiosis - physiology |
1 |
|
animal models |
1 |
|
anoxia |
1 |
|
anthropometry |
1 |
|
anti-bacterial agents - administration & dosage |
1 |
|
anti-bacterial agents - administration & dosage - therapeutic use |
1 |
|
anti-bacterial agents - pharmacokinetics - pharmacology - therapeutic use |
1 |
|
anti-fungal drugs |
1 |
|
anti-hiv agents - therapeutic use |
1 |
|
anti-infective agents - adverse effects |
1 |
|
anti-infective agents - therapeutic use |
1 |
|
anti-infective agents, local - administration & dosage |
1 |
|
anti-infective agents, local - administration & dosage - pharmacology |
1 |
|
anti-infective agents, local - adverse effects - pharmacology - therapeutic use |
1 |
|
anti-infective agents, local - pharmacology |
1 |
|
anti-infective agents, local - therapeutic use |
1 |
|
anti-inflammatory agents - adverse effects |
1 |
|
anti-inflammatory agents - pharmacology |
1 |
|
antibiotic prophylaxis |
1 |
|
antibiotic prophylaxis - utilization |
1 |
|
antifungal activity |
1 |
|
antifungal agents |
1 |
|
antifungal agents - administration & dosage |
1 |
|
antifungal agents - administration & dosage - adverse effects - classification - therapeutic use |
1 |
|
antifungal agents - administration & dosage - classification - therapeutic use |
1 |
|
antifungal agents - administration & dosage - pharmacology |
1 |
|
antifungal agents - administration & dosage - therapeutic use |
1 |
|
antifungal agents - administration and dosage - pharmacology |
1 |
|
antifungal agents - adverse effects - therapeutic use |
1 |
|
antifungal agents - chemical synthesis - pharmacology |
1 |
|
antifungal effect |
1 |
|
antigens, cd95 - metabolism |
1 |
|
antigens, fungal - immunology |
1 |
|
antimicrobial agents |
1 |
|
antimicrobial cationic peptides - chemical synthesis - pharmacology |
1 |
|
antimicrobial susceptibility |
1 |
|
antimycotics |
1 |
|
antineoplastic agents - adverse effects |
1 |
|
antineoplastic agents - pharmacology - therapeutic use |
1 |
|
antiretroviral therapy, highly active - statistics & numerical data |
1 |
|
antitubercular agents - therapeutic use |
1 |
|
apicoectomy |
1 |
|
apoptosis |
1 |
|
areca - adverse effects |
1 |
|
ascorbic acid deficiency - complications |
1 |
|
asia |
1 |
|
asia - epidemiology |
1 |
|
asia, southeastern - epidemiology |
1 |
|
aspartic acid endopeptidases |
1 |
|
aspartic acid endopeptidases - metabolism - secretion |
1 |
|
aspartic acid proteases - metabolism |
1 |
|
aspartic acid proteases - secretion |
1 |
|
aspartyl-protease |
1 |
|
aspergillosis - complications |
1 |
|
asthma - drug therapy |
1 |
|
attitude |
1 |
|
attitude of health personnel |
1 |
|
autoimmune diseases - diagnosis |
1 |
|
azole resistance |
1 |
|
azoles - pharmacology |
1 |
|
azoles - therapeutic use |
1 |
|
bacteria - classification - growth & development - ultrastructure |
1 |
|
bacteria - drug effects - isolation & purification |
1 |
|
bacteria - growth & development - ultrastructure |
1 |
|
bacteria - isolation & purification |
1 |
|
bacteria, anaerobic - drug effects |
1 |
|
bacterial adhesion - drug effects |
1 |
|
bacterial adhesion - immunology |
1 |
|
bacterial infections - diagnosis |
1 |
|
bacterial infections - pathology |
1 |
|
bacterial infections - prevention & control |
1 |
|
bacterial morphotype |
1 |
|
bacteriology |
1 |
|
bacteriophage typing |
1 |
|
bacteroidaceae infections - drug therapy |
1 |
|
bacteroides - metabolism |
1 |
|
bacteroides sp. |
1 |
|
basement membrane - microbiology - ultrastructure |
1 |
|
benzydamine - therapeutic use |
1 |
|
betel |
1 |
|
betel quid chewing |
1 |
|
bicuspid |
1 |
|
biflavonoids - pharmacology |
1 |
|
biofilm formation |
1 |
|
bioflim |
1 |
|
biological markers |
1 |
|
biotyping |
1 |
|
birth weight |
1 |
|
blood |
1 |
|
blood - immunology |
1 |
|
blood - metabolism |
1 |
|
blood - microbiology |
1 |
|
blood physiological phenomena |
1 |
|
blood proteins - pharmacology |
1 |
|
bloodletting |
1 |
|
blotting, western - methods |
1 |
|
boric acids - pharmacology |
1 |
|
bronchoalveolar lavage fluid - immunology |
1 |
|
buccal epithelial cell |
1 |
|
burning mouth |
1 |
|
burning mouth syndrome |
1 |
|
burning mouth syndrome - microbiology |
1 |
|
c. parapsilosis |
1 |
|
cadherins - metabolism |
1 |
|
cambodia |
1 |
|
cambodia - epidemiology |
1 |
|
canada |
1 |
|
candida - classification - drug effects - growth & development |
1 |
|
candida - classification - enzymology |
1 |
|
candida - classification - enzymology - isolation & purification |
1 |
|
candida - classification - genetics |
1 |
|
candida - classification - genetics - immunology - isolation & purification - pathogenicity |
1 |
|
candida - classification - genetics - pathogenicity |
1 |
|
candida - classification - isolation & purification - pathogenicity |
1 |
|
candida - cytology - drug effects |
1 |
|
candida - cytology - isolation & purification - physiology |
1 |
|
candida - drug effects - enzymology - growth & development |
1 |
|
candida - drug effects - enzymology - metabolism |
1 |
|
candida - drug effects - metabolism |
1 |
|
candida - drug effects - physiology |
1 |
|
candida - drug effects - ultrastructure |
1 |
|
candida - enzymology - isolation & purification - pathogenicity |
1 |
|
candida - genetics - growth & development |
1 |
|
candida - genetics - isolation & purification |
1 |
|
candida - immunology |
1 |
|
candida - isolation & purification - physiology |
1 |
|
candida - pathogenicity - physiology |
1 |
|
candida - ultrastructure |
1 |
|
candida albicans - analysis - metabolism |
1 |
|
candida albicans - chemistry - isolation & purification - physiology |
1 |
|
candida albicans - classification - drug effects - enzymology - isolation & purification |
1 |
|
candida albicans - classification - drug effects - enzymology - metabolism |
1 |
|
candida albicans - classification - drug effects - ultrastructure |
1 |
|
candida albicans - classification - enzymology |
1 |
|
candida albicans - classification - enzymology - genetics |
1 |
|
candida albicans - classification - enzymology - isolation & purification |
1 |
|
candida albicans - classification - isolation & purification |
1 |
|
candida albicans - classification - metabolism - pathogenicity |
1 |
|
candida albicans - cytology - drug effects |
1 |
|
candida albicans - drug effects - enzymology |
1 |
|
candida albicans - drug effects - enzymology - growth & development |
1 |
|
candida albicans - drug effects - enzymology - growth & development - metabolism - pathogenicity |
1 |
|
candida albicans - drug effects - enzymology - metabolism |
1 |
|
candida albicans - drug effects - growth & development - pathogenicity |
1 |
|
candida albicans - drug effects - isolation & purification |
1 |
|
candida albicans - drug effects - isolation & purification - pathogenicity |
1 |
|
candida albicans - drug effects - pathogenicity |
1 |
|
candida albicans - drug effects - physiology - ultrastructure |
1 |
|
candida albicans - drug effects - ultrastructure |
1 |
|
candida albicans - enzymology |
1 |
|
candida albicans - enzymology - genetics |
1 |
|
candida albicans - enzymology - growth & development - metabolism |
1 |
|
candida albicans - enzymology - growth & development - physiology |
1 |
|
candida albicans - enzymology - isolation & purification - pathogenicity |
1 |
|
candida albicans - enzymology - physiology |
1 |
|
candida albicans - growth & development - metabolism |
1 |
|
candida albicans - growth & development - ultrastructure |
1 |
|
candida albicans - immunology - pathogenicity |
1 |
|
candida albicans - isolation & purification - physiology |
1 |
|
candida albicans - pathogenicity - physiology |
1 |
|
candida glabrata - chemistry - isolation & purification - physiology |
1 |
|
candida glabrata - classification - metabolism - pathogenicity |
1 |
|
candida glabrata - genetics - isolation & purification |
1 |
|
candida guilliermondii |
1 |
|
candida parapsilosis |
1 |
|
candida tropicalis - drug effects |
1 |
|
candida tropicalis - drug effects - isolation & purification |
1 |
|
candida tropicalis - enzymology |
1 |
|
candidal carriage |
1 |
|
candidiasis - diagnosis - microbiology |
1 |
|
candidiasis, chronic mucocutaneous - classification |
1 |
|
candidiasis, cutaneous - microbiology |
1 |
|
candidiasis, oral |
1 |
|
candidiasis, oral - blood - complications - drug therapy - immunology - microbiology - pathology |
1 |
|
candidiasis, oral - blood - epidemiology - genetics |
1 |
|
candidiasis, oral - blood - etiology |
1 |
|
candidiasis, oral - chemically induced - microbiology |
1 |
|
candidiasis, oral - classification - complications - drug therapy |
1 |
|
candidiasis, oral - classification - complications - pathology |
1 |
|
candidiasis, oral - classification - drug therapy |
1 |
|
candidiasis, oral - classification - drug therapy - immunology - physiopathology |
1 |
|
candidiasis, oral - classification - epidemiology |
1 |
|
candidiasis, oral - complications - epidemiology - pathology |
1 |
|
candidiasis, oral - complications - prevention & control |
1 |
|
candidiasis, oral - diagnosis |
1 |
|
candidiasis, oral - diagnosis - microbiology |
1 |
|
candidiasis, oral - diagnosis - therapy |
1 |
|
candidiasis, oral - drug therapy |
1 |
|
candidiasis, oral - drug therapy - epidemiology - etiology - pathology |
1 |
|
candidiasis, oral - drug therapy - epidemiology - physiopathology |
1 |
|
candidiasis, oral - epidemiology - etiology |
1 |
|
candidiasis, oral - etiology |
1 |
|
candidiasis, oral - etiology - pathology |
1 |
|
candidiasis, oral - etiology - prevention & control |
1 |
|
candidiasis, oral - immunology - microbiology |
1 |
|
candidiasis, oral - pathology |
1 |
|
candidiasis, oral - prevention & control |
1 |
|
candidiasis, review |
1 |
|
candidiasis, vulvovaginal - microbiology |
1 |
|
candidiasis,-oral-classification |
1 |
|
candidiasis,-oral-drug-therapy |
1 |
|
candidiasis,-oral-etiology |
1 |
|
candidosis, oral |
1 |
|
capnocytophaga - metabolism |
1 |
|
capnocytophaga sp. |
1 |
|
carboxy-lyases - genetics - metabolism |
1 |
|
carboxylic acids - analysis - biosynthesis |
1 |
|
carboxylic acids - biosynthesis |
1 |
|
carcinoma, squamous cell - chemistry - genetics - metabolism |
1 |
|
carcinoma, squamous cell - metabolism |
1 |
|
carcinoma, squamous cell - metabolism - pathology |
1 |
|
carcinoma, squamous cell - radiotherapy |
1 |
|
carriage |
1 |
|
carrier proteins - pharmacology |
1 |
|
carrier state |
1 |
|
carrier state - epidemiology |
1 |
|
catechin - pharmacology |
1 |
|
cationic peptide |
1 |
|
cd4-positive t-lymphocytes - pathology |
1 |
|
cdk4 |
1 |
|
ceftazidime - pharmacology |
1 |
|
cefuroxime - pharmacology |
1 |
|
cell adhesion - drug effects |
1 |
|
cell adhesion - immunology |
1 |
|
cell death - drug effects |
1 |
|
cell length |
1 |
|
cell membrane - chemistry |
1 |
|
cell membrane - drug effects |
1 |
|
cell membrane - drug effects - ultrastructure |
1 |
|
cell membrane permeability - drug effects |
1 |
|
cell nucleus - microbiology - ultrastructure |
1 |
|
cell surface hydrophobicity |
1 |
|
cell survival - drug effects |
1 |
|
cell transformation, neoplastic |
1 |
|
cell wall - drug effects |
1 |
|
cell wall - physiology - ultrastructure |
1 |
|
cephalothin - pharmacology |
1 |
|
cheek |
1 |
|
cheek - microbiology |
1 |
|
cheilitis - complications - microbiology |
1 |
|
cheilitis - epidemiology |
1 |
|
cheilitis - epidemiology - microbiology |
1 |
|
cheilitis - microbiology |
1 |
|
cheilitis - microbiology - pathology |
1 |
|
cheilitis - pathology |
1 |
|
child nutrition disorders - complications - epidemiology |
1 |
|
child nutrition disorders - complications - microbiology |
1 |
|
child nutrition disorders - diagnosis |
1 |
|
china - epidemiology |
1 |
|
chlorhexidine - administration & dosage - analogs & derivatives |
1 |
|
chlorhexidine - administration & dosage - analogs & derivatives - pharmacology |
1 |
|
chlorhexidine - adverse effects - pharmacology - therapeutic use |
1 |
|
chlorhexidine - analogs & derivatives - chemistry |
1 |
|
chlorhexidine - therapeutic use |
1 |
|
chlorhexidine gluconate |
1 |
|
chondroitinase |
1 |
|
chondroitinases and chondroitin lyases - analysis |
1 |
|
chondroitinases and chondroitin lyases - metabolism |
1 |
|
chromosomes, fungal - chemistry |
1 |
|
cigarette smoke |
1 |
|
ciprofloxacin - pharmacology |
1 |
|
circular dichroism |
1 |
|
clindamycin - pharmacokinetics - pharmacology - therapeutic use |
1 |
|
clinical audit |
1 |
|
clinical competence - statistics & numerical data |
1 |
|
cloning, molecular |
1 |
|
clotrimazole |
1 |
|
clotrimazole - administration & dosage - therapeutic use |
1 |
|
clotrimazole - pharmacology |
1 |
|
clotrimazole - therapeutic use |
1 |
|
cold-cured acrylic resins |
1 |
|
collagen |
1 |
|
collagen type i - chemistry |
1 |
|
collectins |
1 |
|
colloids |
1 |
|
colorimetry |
1 |
|
colorimetry - economics - methods |
1 |
|
coma |
1 |
|
coma - microbiology |
1 |
|
communicable disease control |
1 |
|
communicable diseases |
1 |
|
communication |
1 |
|
complementation |
1 |
|
congresses as topic |
1 |
|
connective tissue - microbiology - ultrastructure |
1 |
|
coronavirus - pathogenicity |
1 |
|
corticosteroids |
1 |
|
cross infection |
1 |
|
cross infection - etiology - prevention & control |
1 |
|
cross infection - prevention & control - psychology |
1 |
|
cryptococcosis - complications |
1 |
|
csh |
1 |
|
culture media - pharmacology |
1 |
|
culture media, conditioned - chemistry - metabolism |
1 |
|
cuspid |
1 |
|
cyclin a |
1 |
|
cyclin a - metabolism |
1 |
|
cyclin-dependent kinase 4 |
1 |
|
cyclin-dependent kinase inhibitor p16 - biosynthesis |
1 |
|
cyclin-dependent kinases - antagonists & inhibitors - biosynthesis |
1 |
|
cytoplasm - microbiology - ultrastructure |
1 |
|
cytotoxics and radiotherapy |
1 |
|
delayed-action preparations |
1 |
|
dental auxiliaries |
1 |
|
dental auxiliaries - statistics & numerical data |
1 |
|
dental care - psychology |
1 |
|
dental care - psychology - utilization |
1 |
|
dental care for aged - methods |
1 |
|
dental care for aged - statistics & numerical data |
1 |
|
dental care for chronically ill - methods |
1 |
|
dental care for chronically ill - statistics & numerical data |
1 |
|
dental care for disabled |
1 |
|
dental care for disabled - statistics & numerical data |
1 |
|
dental caries - diagnosis - therapy |
1 |
|
dental caries - epidemiology |
1 |
|
dental caries susceptibility |
1 |
|
dental clinics |
1 |
|
dental disinfectants - adverse effects - therapeutic use |
1 |
|
dental enamel |
1 |
|
dental equipment - microbiology |
1 |
|
dental fistula - epidemiology |
1 |
|
dental health surveys |
1 |
|
dental hygienists |
1 |
|
dental implants - adverse effects |
1 |
|
dental impression materials |
1 |
|
dental materials |
1 |
|
dental offices |
1 |
|
dental pellicle |
1 |
|
dental plaque - analysis |
1 |
|
dental plaque - ethnology - microbiology |
1 |
|
dental plaque - etiology - microbiology - ultrastructure |
1 |
|
dental plaque - immunology |
1 |
|
dental plaque - microbiology - ultrastructure |
1 |
|
dental plaque index |
1 |
|
dental practice |
1 |
|
dental practitioners |
1 |
|
dental prophylaxis |
1 |
|
dental pulp diseases - drug therapy - microbiology |
1 |
|
dental pulp diseases - epidemiology |
1 |
|
dental staff - psychology |
1 |
|
dental staff, hospital |
1 |
|
dentist-patient relations |
1 |
|
dentistry, operative - instrumentation |
1 |
|
dentists - psychology |
1 |
|
dentists - psychology - statistics & numerical data |
1 |
|
dentists - statistics & numerical data |
1 |
|
dentition |
1 |
|
dentoalveolar abscess |
1 |
|
denture |
1 |
|
denture arylic |
1 |
|
denture bases |
1 |
|
denture liner |
1 |
|
denture, complete |
1 |
|
denture, complete - adverse effects |
1 |
|
denture, complete - microbiology |
1 |
|
denture, partial, removable |
1 |
|
denture-induced stomatitis |
1 |
|
dentures - adverse effects - statistics & numerical data |
1 |
|
dermatomycoses - drug therapy - microbiology |
1 |
|
dermatomycoses - microbiology |
1 |
|
desmosomes - microbiology - ultrastructure |
1 |
|
developed countries |
1 |
|
developing countries |
1 |
|
diabetes complications - blood - microbiology |
1 |
|
diabetes mellitus - blood - microbiology |
1 |
|
diabetes mellitus - blood - microbiology - prevention & control |
1 |
|
diabetes mellitus - microbiology |
1 |
|
diabetes mellitus, type 1 - blood |
1 |
|
diabetes mellitus, type 1 - blood - complications - microbiology |
1 |
|
diabetes mellitus, type 2 - blood |
1 |
|
diabetes mellitus, type 2 - blood - complications - microbiology |
1 |
|
diagnosis |
1 |
|
diagnosis, differential |
1 |
|
diagnostic tests, routine - economics - methods |
1 |
|
diet |
1 |
|
dietary carbohydrates - adverse effects |
1 |
|
dietary sucrose - pharmacology |
1 |
|
differential count |
1 |
|
diffusion chambers, culture |
1 |
|
direct smears |
1 |
|
disease outbreaks - prevention and control |
1 |
|
disease susceptibility |
1 |
|
dna - chemistry |
1 |
|
dna fingerprinting - methods |
1 |
|
dna, fungal - analysis |
1 |
|
dna, fungal - chemistry |
1 |
|
dose-response relationship, immunologic |
1 |
|
dots |
1 |
|
down-regulation |
1 |
|
drainage |
1 |
|
drug |
1 |
|
drug administration schedule |
1 |
|
drug delivery systems |
1 |
|
drug design |
1 |
|
drug monitoring - methods |
1 |
|
drug prescriptions |
1 |
|
drug resistance, multiple, fungal |
1 |
|
drug therapy |
1 |
|
drug utilization |
1 |
|
duty to warn |
1 |
|
e-cadherin |
1 |
|
ecosystem |
1 |
|
edetic acid - adverse effects - therapeutic use |
1 |
|
education, dental |
1 |
|
electrolytes |
1 |
|
electrolytes - analysis |
1 |
|
electron microscopy |
1 |
|
electrophoresis |
1 |
|
electrophoresis, agar gel |
1 |
|
emerging diseases |
1 |
|
endocarditis - microbiology |
1 |
|
endopeptidases - biosynthesis |
1 |
|
endopeptidases - metabolism |
1 |
|
endotoxins - analysis |
1 |
|
england |
1 |
|
enteric gram-negative rod |
1 |
|
enterobacter cloacae |
1 |
|
enterobacter cloacae - drug effects |
1 |
|
enterobacteriaceae - drug effects - isolation & purification |
1 |
|
enterobacteriaceae - isolation and purification |
1 |
|
enzyme-linked immunosorbent assay - methods |
1 |
|
epithelial cells - drug effects - microbiology |
1 |
|
epithelial cells - microbiology - physiology - ultrastructure |
1 |
|
epithelium |
1 |
|
epithelium - drug effects |
1 |
|
epithelium - microbiology - ultrastructure |
1 |
|
equipment design |
1 |
|
equipment failure |
1 |
|
ergosterol - pharmacology |
1 |
|
erythema |
1 |
|
erythema - microbiology |
1 |
|
erythema - pathology |
1 |
|
erythromycin - pharmacology |
1 |
|
escherichia coli - drug effects - isolation & purification |
1 |
|
escherichia coli - immunology |
1 |
|
escherichia coli - isolation & purification - physiology |
1 |
|
europe - epidemiology |
1 |
|
european continental ancestry group |
1 |
|
exostoses - epidemiology |
1 |
|
experimental gingivitis |
1 |
|
extracellular matrix - drug effects |
1 |
|
fas |
1 |
|
fas ligand protein |
1 |
|
fasl |
1 |
|
fear |
1 |
|
fibrin |
1 |
|
fibronectin |
1 |
|
fibronectins - pharmacology |
1 |
|
filtration - instrumentation - methods |
1 |
|
finland |
1 |
|
florida |
1 |
|
fluconazole - administration & dosage - pharmacology |
1 |
|
fluconazole - administration & dosage - therapeutic use |
1 |
|
fluconazole - pharmacology - therapeutic use |
1 |
|
flucytosine - administration & dosage - pharmacology |
1 |
|
flucytosine - pharmacology |
1 |
|
flucytosine - pharmacology - therapeutic use |
1 |
|
flucytosine - therapeutic use |
1 |
|
fluorides, topical - pharmacology |
1 |
|
fluorides, topical - therapeutic use |
1 |
|
focal infection, dental - drug therapy - microbiology |
1 |
|
folic acid deficiency - complications |
1 |
|
food microbiology |
1 |
|
forecasting |
1 |
|
formaldehyde - pharmacology |
1 |
|
fungal infections |
1 |
|
fungal proteins - physiology |
1 |
|
fungal proteins - secretion |
1 |
|
fungemia - microbiology |
1 |
|
fusidic acid - pharmacology |
1 |
|
g1 phase - physiology |
1 |
|
gelatin |
1 |
|
gelatin - chemistry |
1 |
|
gene deletion |
1 |
|
gene expression regulation, fungal - physiology |
1 |
|
gene expression regulation, neoplastic |
1 |
|
general practice, dental |
1 |
|
genes, tumor suppressor - genetics |
1 |
|
genetic complementation test |
1 |
|
genetic variation - genetics |
1 |
|
gentamicins - pharmacology |
1 |
|
geography |
1 |
|
geotrichosis - complications |
1 |
|
geriatric assessment |
1 |
|
germ tube |
1 |
|
germ tube and post-antifungal effect (pafe) |
1 |
|
germ-tube |
1 |
|
gerodontology |
1 |
|
gingival hyperplasia |
1 |
|
gingivitis - drug therapy |
1 |
|
gingivitis - prevention & control |
1 |
|
glass - chemistry |
1 |
|
glossitis - complications |
1 |
|
glossitis - microbiology |
1 |
|
gloves, surgical |
1 |
|
gloves, surgical - statistics & numerical data |
1 |
|
glucan endo-1,3-beta-d-glucosidase - pharmacology |
1 |
|
glucocorticoids - adverse effects |
1 |
|
glucose - analysis |
1 |
|
glutaral - pharmacology |
1 |
|
glycoproteins |
1 |
|
glycoproteins - analysis |
1 |
|
gossypium |
1 |
|
gram-negative aerobic bacteria - isolation & purification |
1 |
|
gram-negative bacteria - physiology |
1 |
|
gram-positive bacteria - isolation & purification |
1 |
|
great britain - epidemiology |
1 |
|
growth disorders - diagnosis |
1 |
|
growth media |
1 |
|
guidelines as topic |
1 |
|
haemolysin |
1 |
|
haemolysis |
1 |
|
haemophilus - metabolism |
1 |
|
handwashing |
1 |
|
health |
1 |
|
health education, dental |
1 |
|
health personnel |
1 |
|
health policy |
1 |
|
health services needs and demand - statistics & numerical data |
1 |
|
heat-cured acrylic resins |
1 |
|
hemolysin proteins - genetics |
1 |
|
hemolysin proteins - isolation & purification |
1 |
|
hemolysis |
1 |
|
hepatitis b |
1 |
|
hepatitis b - epidemiology - immunology - transmission |
1 |
|
hepatitis b - epidemiology - prevention & control |
1 |
|
hepatitis b - prevention & control |
1 |
|
hepatitis b - prevention & control - transmission |
1 |
|
hepatitis b - psychology - transmission |
1 |
|
hepatitis b - transmission |
1 |
|
hepatitis b antibodies - blood |
1 |
|
hepatitis b surface antigens - analysis |
1 |
|
hepatitis b vaccine |
1 |
|
hepatitis b vaccines |
1 |
|
hepatitis b vaccines - administration & dosage |
1 |
|
hepatitis b virus - immunology |
1 |
|
hepatitis viruses |
1 |
|
hepatitis, viral, human - epidemiology - prevention & control - transmission |
1 |
|
histoplasmosis - complications |
1 |
|
hiv antibodies - analysis |
1 |
|
hiv infections |
1 |
|
hiv infections - complications - drug therapy |
1 |
|
hiv infections - complications - epidemiology |
1 |
|
hiv infections - complications - immunology |
1 |
|
hiv infections - complications - psychology - transmission |
1 |
|
hiv infections - epidemiology |
1 |
|
hiv infections - epidemiology - transmission |
1 |
|
hiv infections - etiology - transmission |
1 |
|
hiv infections - prevention & control - therapy - transmission |
1 |
|
hiv infections - psychology - transmission |
1 |
|
hiv seronegativity |
1 |
|
hiv seropositivity |
1 |
|
hiv seropositivity - blood - diagnosis |
1 |
|
hiv seropositivity - classification - complications - epidemiology |
1 |
|
hiv seropositivity - complications |
1 |
|
hiv seropositivity - diagnosis |
1 |
|
hiv seropositivity - epidemiology |
1 |
|
hiv seropositivity - microbiology |
1 |
|
hiv seroprevalence |
1 |
|
hiv, candidosis/candidiasis, oral |
1 |
|
hiv-1 - immunology |
1 |
|
hiv-1 - isolation & purification |
1 |
|
hiv-1 infection |
1 |
|
hiv‐infection |
1 |
|
hlp gene |
1 |
|
homes for the aged |
1 |
|
homozygote |
1 |
|
homozygous deletion |
1 |
|
hormone |
1 |
|
hospital care |
1 |
|
hospital department |
1 |
|
hospital units |
1 |
|
hospitalised |
1 |
|
hospitals, urban |
1 |
|
hot temperature |
1 |
|
hydrocarbons |
1 |
|
hydrolases - analysis - physiology |
1 |
|
hydrophobicity, bacterial |
1 |
|
hydroxyapatites |
1 |
|
hyperplasia |
1 |
|
hyperplastic candidosis |
1 |
|
hypersensitivity - immunology |
1 |
|
hyphae - metabolism |
1 |
|
hyphal phase |
1 |
|
imidazole antibiotics |
1 |
|
immunity, cellular |
1 |
|
immunization, secondary - adverse effects |
1 |
|
immunization, secondary - utilization |
1 |
|
immunocompetence |
1 |
|
immunocompetence - immunology |
1 |
|
immunodeficiency |
1 |
|
immunoglobulin |
1 |
|
immunoglobulin a, secretory - metabolism |
1 |
|
immunoglobulin g - analysis |
1 |
|
immunosuppressive agents - adverse effects |
1 |
|
india |
1 |
|
indigenous bacteria |
1 |
|
infant |
1 |
|
infant nutrition disorders - complications - epidemiology |
1 |
|
infant, newborn |
1 |
|
infection control - legislation & jurisprudence - methods |
1 |
|
infection control, dental |
1 |
|
infectious disease transmission, patient-to-professional - statistics & numerical data |
1 |
|
infectious disease transmission, professional-to-patient - prevention & control |
1 |
|
institutionalized |
1 |
|
intercellular junctions - microbiology - ultrastructure |
1 |
|
internationality |
1 |
|
interprofessional relations |
1 |
|
ireland |
1 |
|
iron - deficiency |
1 |
|
isoelectric point |
1 |
|
itraconazole - administration & dosage - therapeutic use |
1 |
|
itraconazole - therapeutic use |
1 |
|
jaw, edentulous - microbiology |
1 |
|
journalism, dental |
1 |
|
keratinocytes - metabolism - microbiology |
1 |
|
keratosis - microbiology - pathology |
1 |
|
ketoconazole |
1 |
|
ketoconazole - administration & dosage - pharmacology |
1 |
|
ketoconazole - administration & dosage - therapeutic use |
1 |
|
ketoconazole - pharmacology |
1 |
|
ketoconazole - pharmacology - therapeutic use |
1 |
|
klebsiella pneumoniae |
1 |
|
klebsiella pneumoniae - drug effects |
1 |
|
lacquer |
1 |
|
lactobacillus casei - physiology |
1 |
|
lactoferrin - therapeutic use |
1 |
|
latex |
1 |
|
leprosy |
1 |
|
leukaemia |
1 |
|
leukoedema, oral - epidemiology - pathology |
1 |
|
leukoedema, oral - etiology |
1 |
|
leukoplakia, oral - blood - epidemiology - genetics |
1 |
|
leukoplakia, oral - chemistry - genetics - metabolism |
1 |
|
leukoplakia, oral - complications - etiology - pathology |
1 |
|
leukoplakia, oral - drug therapy |
1 |
|
leukoplakia, oral - etiology - microbiology |
1 |
|
leukoplakia, oral - etiology - pathology - therapy |
1 |
|
lichen planus - microbiology |
1 |
|
lichen planus, oral - etiology |
1 |
|
local delivery |
1 |
|
london |
1 |
|
long term care |
1 |
|
long-term care |
1 |
|
longitudinal |
1 |
|
lymph nodes - physiopathology |
1 |
|
lymphadenitis - epidemiology |
1 |
|
lymphoma, aids-related - therapy |
1 |
|
malignancies |
1 |
|
malignant transformation |
1 |
|
malnutrition |
1 |
|
mandibular diseases - epidemiology |
1 |
|
mannan-binding protein |
1 |
|
mass screening |
1 |
|
mass screening - organization & administration |
1 |
|
mastication |
1 |
|
materials testing |
1 |
|
maternal-child health centers |
1 |
|
maxillary diseases - epidemiology |
1 |
|
mdr-tb |
1 |
|
medline |
1 |
|
membrane glycoproteins - antagonists & inhibitors |
1 |
|
membrane glycoproteins - metabolism |
1 |
|
membranes, artificial |
1 |
|
metabolizm |
1 |
|
method |
1 |
|
methylmethacrylate |
1 |
|
methylmethacrylates |
1 |
|
metronidazole - administration & dosage |
1 |
|
mevalonate diphosphate decarboxylase |
1 |
|
mic |
1 |
|
mice |
1 |
|
miconazole |
1 |
|
miconazole - administration & dosage - therapeutic use |
1 |
|
miconazole - pharmacology |
1 |
|
miconazole - therapeutic use |
1 |
|
microsatellite repeats - genetics |
1 |
|
microscopy |
1 |
|
microscopy, electron |
1 |
|
minimum inhibitory concentration (mic) |
1 |
|
mitochondria - enzymology |
1 |
|
molar |
1 |
|
morphology |
1 |
|
mott |
1 |
|
mouth - cytology - microbiology |
1 |
|
mouth - drug effects - microbiology |
1 |
|
mouth - immunology - microbiology |
1 |
|
mouth - microbiology - pathology |
1 |
|
mouth - physiology |
1 |
|
mouth - surgery |
1 |
|
mouth diseases |
1 |
|
mouth diseases - complications - epidemiology - pathology |
1 |
|
mouth diseases - drug therapy |
1 |
|
mouth diseases - epidemiology |
1 |
|
mouth diseases - epidemiology - ethnology |
1 |
|
mouth diseases - etiology |
1 |
|
mouth diseases - etiology - microbiology |
1 |
|
mouth diseases - etiology - therapy |
1 |
|
mouth diseases - pathology |
1 |
|
mouth floor |
1 |
|
mouth mucosa |
1 |
|
mouth mucosa - chemistry - metabolism |
1 |
|
mouth mucosa - cytology |
1 |
|
mouth mucosa - immunology - pathology |
1 |
|
mouth mucosa - microbiology - physiology - ultrastructure |
1 |
|
mouth mucosa - microbiology - ultrastructure |
1 |
|
mouth mucosa - pathology |
1 |
|
mouth neoplasms - chemistry - genetics - metabolism |
1 |
|
mouth neoplasms - epidemiology |
1 |
|
mouth neoplasms - metabolism |
1 |
|
mouth neoplasms - metabolism - pathology |
1 |
|
mouth neoplasms - microbiology |
1 |
|
mouth neoplasms - radiotherapy |
1 |
|
mouth, edentulous - epidemiology |
1 |
|
mouth, edentulous - microbiology |
1 |
|
mouthwashes - pharmacology |
1 |
|
mucin |
1 |
|
mucins - pharmacology |
1 |
|
mucocele - epidemiology |
1 |
|
muramidase - therapeutic use |
1 |
|
mycoses - complications |
1 |
|
mycoses - complications - drug therapy - epidemiology |
1 |
|
mycoses - complications - microbiology |
1 |
|
mycoses - epidemiology - microbiology |
1 |
|
natural sciences |
1 |
|
needlestick injuries - complications |
1 |
|
needlestick injuries - etiology |
1 |
|
neoplasms - complications - therapy |
1 |
|
neoplasms - diagnosis |
1 |
|
nephelometry and turbidimetry |
1 |
|
neutrophils - immunology |
1 |
|
normoxia |
1 |
|
nsaid |
1 |
|
nucleic acid amplification techniques - methods |
1 |
|
nutrition assessment |
1 |
|
nutrition disorders - complications |
1 |
|
nutritional status |
1 |
|
nystatin |
1 |
|
nystatin - administration & dosage |
1 |
|
nystatin - administration & dosage - pharmacology |
1 |
|
nystatin - administration & dosage - therapeutic use |
1 |
|
nystatin - pharmacology - therapeutic use |
1 |
|
nystatin - therapeutic use |
1 |
|
nystatin postantifungal effect (pafe) |
1 |
|
occupational dentistry |
1 |
|
occupational diseases - epidemiology |
1 |
|
occupational diseases - prevention & control |
1 |
|
occupational diseases - transmission |
1 |
|
occupational exposure - prevention & control |
1 |
|
opportunistic infections - chemically induced - microbiology |
1 |
|
opportunistic infections - classification - drug therapy |
1 |
|
opportunistic infections - drug therapy |
1 |
|
opportunistic infections - etiology |
1 |
|
oral c. albicans |
1 |
|
oral candidoses |
1 |
|
oral candidosis |
1 |
|
oral carriage |
1 |
|
oral colonization |
1 |
|
oral disease |
1 |
|
oral epithelium |
1 |
|
oral hygiene - methods |
1 |
|
oral hygiene - statistics & numerical data |
1 |
|
oral infection |
1 |
|
oral medicine |
1 |
|
oral submucous fibrosis |
1 |
|
oral submucous fibrosis - microbiology |
1 |
|
oral ulcer - microbiology |
1 |
|
organ culture techniques |
1 |
|
organ size |
1 |
|
organizational policy |
1 |
|
orofacial infection |
1 |
|
oropharyngeal |
1 |
|
oropharyngeal candidiasis |
1 |
|
otitis - microbiology |
1 |
|
p16 |
1 |
|
p53 proteins |
1 |
|
palate |
1 |
|
palate - microbiology |
1 |
|
palate - microbiology - pathology |
1 |
|
palate - pathology |
1 |
|
papillary hyperplasia |
1 |
|
papilloma - epidemiology |
1 |
|
paraffin |
1 |
|
paraffin embedding |
1 |
|
parotid saliva |
1 |
|
pathogenesis |
1 |
|
pathology |
1 |
|
patient acceptance of health care |
1 |
|
patient education as topic |
1 |
|
patients - psychology |
1 |
|
penicillin g - pharmacology |
1 |
|
penicillium - isolation & purification |
1 |
|
penicillium - pathogenicity |
1 |
|
penicillium marneffei |
1 |
|
peptostreptococcus |
1 |
|
peptostreptococcus - isolation & purification |
1 |
|
peptostreptococcus - metabolism |
1 |
|
perception |
1 |
|
periapical abscess - epidemiology |
1 |
|
periapical abscess - microbiology - surgery |
1 |
|
periapical diseases - epidemiology |
1 |
|
periapical diseases - microbiology - surgery |
1 |
|
periodontal abscess - microbiology - surgery |
1 |
|
periodontal abscess - pathology |
1 |
|
periodontitis - drug therapy |
1 |
|
periodontitis - drug therapy - etiology - microbiology |
1 |
|
periodontitis - drug therapy - microbiology |
1 |
|
periodontitis - microbiology |
1 |
|
periodontitis - surgery |
1 |
|
phosphatidylcholines - metabolism |
1 |
|
phospholipases - analysis |
1 |
|
phospholipases - antagonists & inhibitors - biosynthesis |
1 |
|
phospholipases - biosynthesis - metabolism |
1 |
|
phospholipases - metabolism |
1 |
|
phosphoric monoester hydrolases - genetics - metabolism |
1 |
|
photomicrography |
1 |
|
pilot projects |
1 |
|
placenta - anatomy & histology |
1 |
|
planktonic |
1 |
|
polyene antibiotics |
1 |
|
polyenes - pharmacology |
1 |
|
polymerase chain reaction - methods |
1 |
|
polymorphism |
1 |
|
polymorphism, genetic - genetics |
1 |
|
polymorphism, single-stranded conformational |
1 |
|
polypropylenes |
1 |
|
polyvinyls |
1 |
|
porphyromonas gingivalis - immunology |
1 |
|
porphyromonas gingivalis - physiology |
1 |
|
post antifungal effect (pafe) |
1 |
|
post-antifungal effect |
1 |
|
post-antifungal effect (pafe) |
1 |
|
postantifungal effect (pafe) |
1 |
|
postoperative care |
1 |
|
pregnancy |
1 |
|
premalignancy |
1 |
|
premalignant lesions |
1 |
|
premedication |
1 |
|
prevention |
1 |
|
prevotella intermedia - physiology |
1 |
|
prognosis |
1 |
|
propionic acids - metabolism |
1 |
|
prosthetic material |
1 |
|
protease |
1 |
|
protective clothing |
1 |
|
protein structure, secondary |
1 |
|
protein transport - drug effects |
1 |
|
protein-energy malnutrition - complications |
1 |
|
proteinases |
1 |
|
proto-oncogene proteins |
1 |
|
pseudomonadaceae - isolation & purification |
1 |
|
pseudomonas aeruginosa - drug effects |
1 |
|
pten |
1 |
|
pten phosphohydrolase |
1 |
|
public opinion |
1 |
|
pulsed-field gel electrophoresis |
1 |
|
pyrazoles - therapeutic use |
1 |
|
pyruvates - analysis |
1 |
|
pyruvates - metabolism |
1 |
|
pyruvic acid |
1 |
|
quality assurance, health care - organization & administration |
1 |
|
quantification |
1 |
|
questionnaires |
1 |
|
radiotherapy - adverse effects |
1 |
|
randomly amplified polymorphic dna |
1 |
|
rate of plaque formation |
1 |
|
reagent strips |
1 |
|
referral and consultation |
1 |
|
refugees - statistics & numerical data |
1 |
|
replica |
1 |
|
replica techniques |
1 |
|
reproducibility of results |
1 |
|
retirement |
1 |
|
reverse transcriptase polymerase chain reaction - methods |
1 |
|
rna, fungal - genetics |
1 |
|
rna, messenger - genetics |
1 |
|
root caries - epidemiology |
1 |
|
rt-pcr |
1 |
|
rubber |
1 |
|
s phase - physiology |
1 |
|
saccharomyces cerevisiae |
1 |
|
saccharomyces cerevisiae - metabolism |
1 |
|
saliva - analysis |
1 |
|
saliva - chemistry |
1 |
|
saliva - chemistry - microbiology - virology |
1 |
|
saliva - chemistry - secretion |
1 |
|
saliva - enzymology - microbiology |
1 |
|
saliva - immunology |
1 |
|
saliva - metabolism - microbiology - physiology |
1 |
|
saliva - physiology |
1 |
|
saliva - virology |
1 |
|
salivary gland diseases - radiography |
1 |
|
salivary iga |
1 |
|
salivary proteins and peptides - administration and dosage - pharmacology |
1 |
|
salivary proteins and peptides - analysis |
1 |
|
salivary proteins and peptides - metabolism |
1 |
|
salivation |
1 |
|
salivette |
1 |
|
sarcoma, kaposi - drug therapy - radiotherapy |
1 |
|
sars virus |
1 |
|
schools, dental - organization & administration |
1 |
|
science |
1 |
|
scotland |
1 |
|
scotland - epidemiology |
1 |
|
secreted aspartyl protease (sap) |
1 |
|
secretor status |
1 |
|
secretory aspartyl protease |
1 |
|
self medication |
1 |
|
sem |
1 |
|
semi-automation |
1 |
|
sepsis - etiology |
1 |
|
sepsis - etiology - microbiology |
1 |
|
sepsis - microbiology |
1 |
|
seroepidemiologic studies |
1 |
|
serum |
1 |
|
serum albumin, bovine - pharmacology |
1 |
|
severe acute respiratory syndrome - epidemiology - pathology - transmission - virology |
1 |
|
severe acute respiratory syndrome - epidemiology - prevention and control |
1 |
|
severe acute respiratory syndrome - prevention & control - transmission - virology |
1 |
|
severe acute respiratory syndrome - prevention and control - transmission |
1 |
|
severe acute respiratory syndrome - transmission |
1 |
|
sex distribution |
1 |
|
sialography - adverse effects - methods |
1 |
|
siloxanes |
1 |
|
skin diseases, infectious - surgery |
1 |
|
smoke |
1 |
|
smoking |
1 |
|
smoking - adverse effects |
1 |
|
social environment |
1 |
|
societies, dental |
1 |
|
sodium hypochlorite - adverse effects - therapeutic use |
1 |
|
sodium hypochlorite - pharmacology |
1 |
|
south africa |
1 |
|
south africa - epidemiology |
1 |
|
southern chinese |
1 |
|
spain - epidemiology |
1 |
|
specialties, dental |
1 |
|
specimen handling |
1 |
|
specimen handling - instrumentation - methods |
1 |
|
specimen handling - methods |
1 |
|
spectrophotometry |
1 |
|
spores, fungal |
1 |
|
spores, fungal - isolation & purification |
1 |
|
sputum - microbiology |
1 |
|
squamous cell carcinoma |
1 |
|
squamous cell carcinomas |
1 |
|
staphylococcal infections - microbiology |
1 |
|
staphylococci |
1 |
|
staphylococcus - isolation and purification |
1 |
|
staphylococcus aureus - classification - drug effects |
1 |
|
staphylococcus aureus - drug effects - isolation & purification |
1 |
|
staphylococcus phages |
1 |
|
sterilization - methods |
1 |
|
sterilization - utilization |
1 |
|
steroids |
1 |
|
stomatitis - etiology - microbiology - therapy |
1 |
|
stomatitis, aphthous - drug therapy |
1 |
|
stomatitis, denture - drug therapy - etiology - microbiology |
1 |
|
stomatitis, denture - drug therapy - microbiology |
1 |
|
stomatitis, denture - epidemiology - etiology |
1 |
|
stomatitis, denture - microbiology |
1 |
|
stomatitis, herpetic - drug therapy |
1 |
|
stomatognathic diseases |
1 |
|
streptococcal infections |
1 |
|
streptococcal infections - pathology |
1 |
|
streptococcos mutans |
1 |
|
streptococcus - isolation & purification |
1 |
|
streptococcus - isolation & purification - physiology |
1 |
|
streptococcus - metabolism |
1 |
|
streptococcus - physiology |
1 |
|
streptococcus mutans - drug effects - isolation & purification |
1 |
|
streptococcus mutans - physiology |
1 |
|
streptococcus sanguis - immunology |
1 |
|
streptococcus sanguis - physiology |
1 |
|
streptococcus sp. |
1 |
|
students, dental - psychology |
1 |
|
sucrose |
1 |
|
suction |
1 |
|
sulfides |
1 |
|
superficial |
1 |
|
suppuration |
1 |
|
tabagism |
1 |
|
taiwan - epidemiology |
1 |
|
tanzania |
1 |
|
tanzania - epidemiology |
1 |
|
tea - chemistry |
1 |
|
tea polyphenols |
1 |
|
temperature |
1 |
|
terbinafine |
1 |
|
terminology as topic |
1 |
|
tetracycline - administration & dosage |
1 |
|
tetracycline - pharmacology |
1 |
|
tetrazolium salts |
1 |
|
tetrazolium salts - metabolism |
1 |
|
thailand |
1 |
|
thrombosis - microbiology |
1 |
|
tin fluorides - pharmacology |
1 |
|
tin fluorides - therapeutic use |
1 |
|
tissue culture |
1 |
|
tissue models |
1 |
|
tongue - microbiology |
1 |
|
tongue - pathology |
1 |
|
tongue diseases - microbiology |
1 |
|
tooth discoloration - etiology |
1 |
|
tooth diseases - drug therapy |
1 |
|
tooth enamel |
1 |
|
toothpastes - therapeutic use |
1 |
|
transmission electron microscopy |
1 |
|
treatment failure |
1 |
|
triazole antibiotics |
1 |
|
triazoles - administration & dosage - classification - therapeutic use |
1 |
|
triazoles - therapeutic use |
1 |
|
trimethoprim-sulfamethoxazole combination - pharmacology |
1 |
|
tuberculosis |
1 |
|
tuberculosis, oral - diagnosis |
1 |
|
tuberculosis, pulmonary - diagnosis |
1 |
|
tumor suppressor protein p53 - genetics - metabolism |
1 |
|
tumor suppressor proteins |
1 |
|
tunicamycin |
1 |
|
tunicamycin - pharmacology |
1 |
|
ulcer - epidemiology |
1 |
|
united states - epidemiology |
1 |
|
unnecessary procedures |
1 |
|
urban health |
1 |
|
vaccination - utilization |
1 |
|
variants |
1 |
|
veillonella - isolation & purification |
1 |
|
veillonella - metabolism |
1 |
|
vietnam - epidemiology - ethnology |
1 |
|
viral hepatitis vaccines |
1 |
|
viral hepatitis vaccines - administration & dosage |
1 |
|
viral hepatitis vaccines - isolation & purification - therapeutic use |
1 |
|
viral load |
1 |
|
viral vaccines |
1 |
|
virulence - drug effects |
1 |
|
virulence - physiology |
1 |
|
virulence mechanisms |
1 |
|
virus diseases - diagnosis |
1 |
|
vitamin a deficiency - complications |
1 |
|
vitamin b 12 deficiency - complications |
1 |
|
vitamin b deficiency - complications |
1 |
|
wales |
1 |
|
water |
1 |
|
water supply |
1 |
|
wettability |
1 |
|
world health |
1 |
|
xerostomia - drug therapy |
1 |
|
xerostomia - epidemiology |
1 |
|
xylene |
1 |
|
xylitol |
1 |
|
yeast growth |
1 |
|
yeasts - isolation and purification |
1 |
